Your cart

Your cart is empty

THIS CONTENT IS EXCLUSIVE TO SAGED MEMBERS.🔒

Please log in to your member account or sign up to view these contents in full.

Polycystic Ovarian Syndrome (PCOS) and Medical Cannabis

1 LEARNING CREDITS

    • Overview

      Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder¹ , affecting 12-21% of women of reproductive age.² Despite its widespread occurrence, only 30% of those with PCOS are diagnosed², often only when complications begin to severely impact their quality of life.³

      This module explores the potential of medical cannabis as an adjunct treatment for PCOS, offering new hope for managing symptoms and improving patient outcomes.

      Preview this module by watching the video above.

      Estimated Duration: 1 hour

      Access Duration: 12 months from date of purchase

      Learning Outcomes

      Upon completion of this module, you’ll be able to:

      • Explain the pathophysiology, symptomatology and effects of PCOS
      • Identify conventional interventions for PCOS and describe their potential strengths and drawbacks
      • Discuss medical cannabis' mechanisms of action and therapeutic potential for treating symptoms of PCOS (e.g. pain, low mood, anxiety and sleep problems)
      • Identify considerations and risks for selecting medical cannabis products to treat PCOS

      References

      ¹ Amiri, Fatemeh Nasiri, et al. “The Experience of Women Affected by Polycystic Ovary Syndrome: A Qualitative Study from Iran.” International Journal of Endocrinology and Metabolism, vol. 12, no. 2, Apr. 2014, https://doi.org/10.5812/ijem.13612. Accessed 26 June 2024.

      ² Boyle, Jacqueline, and Helena J. Teede. “Polycystic Ovary Syndrome.” Australian Family Physician, vol. 41, no. 10, Oct. 2012, www.racgp.org.au/afp/2012/october/polycystic-ovary-syndrome. Accessed 26 June 2024.

      ³ Singh, Samradhi, et al. “Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics.” Journal of Clinical Medicine, vol. 12, no. 4, Feb. 2023, p. 1454, https://doi.org/10.3390/jcm12041454. Accessed 26 June 2024.

    Overview

    Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder¹ , affecting 12-21% of women of reproductive age.² Despite its widespread occurrence, only 30% of those with PCOS are diagnosed², often only when complications begin to severely impact their quality of life.³

    This module explores the potential of medical cannabis as an adjunct treatment for PCOS, offering new hope for managing symptoms and improving patient outcomes.

    Preview this module by watching the video above.

    Estimated Duration: 1 hour

    Access Duration: 12 months from date of purchase

    Learning Outcomes

    Upon completion of this module, you’ll be able to:

    • Explain the pathophysiology, symptomatology and effects of PCOS
    • Identify conventional interventions for PCOS and describe their potential strengths and drawbacks
    • Discuss medical cannabis' mechanisms of action and therapeutic potential for treating symptoms of PCOS (e.g. pain, low mood, anxiety and sleep problems)
    • Identify considerations and risks for selecting medical cannabis products to treat PCOS

    References

    ¹ Amiri, Fatemeh Nasiri, et al. “The Experience of Women Affected by Polycystic Ovary Syndrome: A Qualitative Study from Iran.” International Journal of Endocrinology and Metabolism, vol. 12, no. 2, Apr. 2014, https://doi.org/10.5812/ijem.13612. Accessed 26 June 2024.

    ² Boyle, Jacqueline, and Helena J. Teede. “Polycystic Ovary Syndrome.” Australian Family Physician, vol. 41, no. 10, Oct. 2012, www.racgp.org.au/afp/2012/october/polycystic-ovary-syndrome. Accessed 26 June 2024.

    ³ Singh, Samradhi, et al. “Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics.” Journal of Clinical Medicine, vol. 12, no. 4, Feb. 2023, p. 1454, https://doi.org/10.3390/jcm12041454. Accessed 26 June 2024.

    CONTENT EXCLUSIVE TO MEMBERS

    LOG IN OR SIGN UP